Document:

Second Supplemental Indenture

 Exhibit 4.3 

Execution Version 

Second Supplemental Indenture (this “Supplemental Indenture”), dated as of July 13, 2010 among AHNY-DME LLC and
AHNY-IV LLC (each, a “Guaranteeing Subsidiary” and collectively, the “Guaranteeing Subsidiaries”), subsidiaries of Apria Healthcare Group Inc., a Delaware corporation (the “Company”), and U.S. Bank
National Association, as trustee (the “Trustee”). 
 W I T N E S S E T H 

WHEREAS, Apria Healthcare Group Inc. and each of the Guarantors (as defined in the Indenture referred to below) has heretofore executed
and delivered to the Trustee an indenture dated as of May 27, 2009 (as amended by the Supplemental Indenture dated August 13, 2009, the “Indenture”), providing for the issuance of 11.25% Senior Secured Notes due 2014
(Series A-1) (the “Series A-1 Notes”) and Senior Secured Notes due 2014 (Series A-2) (the “Series A-2 Notes” and, together with the Series A-1 Notes, the “Notes”); 

WHEREAS, the Indenture provides that under certain circumstances the Guaranteeing Subsidiaries shall execute and deliver to the Trustee a
supplemental indenture pursuant to which each Guaranteeing Subsidiary shall unconditionally guarantee all of the Company’s Obligations under the Notes and the Indenture on the terms and conditions set forth herein and under the Indenture (the
“Guarantee”); and 
 WHEREAS, pursuant to Section 9.01 of the Indenture, the Trustee is authorized to
execute and deliver this Supplemental Indenture. 
 NOW THEREFORE, in consideration of the foregoing and for other good and
valuable consideration, the receipt of which is hereby acknowledged, the parties mutually covenant and agree for the equal and ratable benefit of the Holders of the Notes as follows: 

(1) Capitalized Terms. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.

 (2) Agreement to Guarantee. Each Guaranteeing Subsidiary hereby agrees as follows: 

(a) Along with all Guarantors named in the Indenture, to jointly and severally unconditionally guarantee to each Holder of
a Note authenticated and delivered by the Trustee and to the Trustee and its successors and assigns, irrespective of the validity and enforceability of the Indenture, the Notes or the obligations of the Company hereunder or thereunder, that:

 (i) the principal of and interest, premium and Additional Interest, if any, on the Notes will be promptly paid
in full when due, whether at maturity, by acceleration, redemption or otherwise, and interest on the overdue principal of and interest on the Notes, if any, if lawful, and all other obligations of the Company to the Holders or the Trustee hereunder
or thereunder will be promptly paid in full or performed, all in accordance with the terms hereof and thereof; and 

(ii) in case of any extension of time of payment or renewal of any Notes or any of such other obligations, that same will
be promptly paid in full when due or performed in accordance with the terms of the extension or renewal, whether at stated 

 
maturity, by acceleration or otherwise. Failing payment when due of any amount so guaranteed or any performance so guaranteed for whatever reason, the Guarantors and such Guaranteeing Subsidiary
shall be jointly and severally obligated to pay the same immediately. This is a guarantee of payment and not a guarantee of collection. 

(b) The obligations hereunder shall be unconditional, irrespective of the validity, regularity or enforceability of the
Notes or the Indenture, the absence of any action to enforce the same, any waiver or consent by any Holder of the Notes with respect to any provisions hereof or thereof, the recovery of any judgment against the Company, any action to enforce the
same or any other circumstance which might otherwise constitute a legal or equitable discharge or defense of a guarantor. 

(c) The following is hereby waived: diligence, presentment, demand of payment, filing of claims with a court in the event
of insolvency or bankruptcy of the Company, any right to require a proceeding first against the Company, protest, notice and all demands whatsoever. 

(d) This Guarantee shall not be discharged except by complete performance of the obligations contained in the Notes, the
Indenture, the Collateral Documents and this Supplemental Indenture, and such Guaranteeing Subsidiary accepts all obligations of a Guarantor under the Indenture. 

(e) If any Holder or the Trustee is required by any court or otherwise to return to the Company, the Guarantors (including
such Guaranteeing Subsidiary), or any custodian, trustee, liquidator or other similar official acting in relation to either the Company or the Guarantors, any amount paid either to the Trustee or such Holder, this Guarantee, to the extent
theretofore discharged, shall be reinstated in full force and effect. 
 (f) Such Guaranteeing Subsidiary shall
not be entitled to any right of subrogation in relation to the Holders in respect of any obligations guaranteed hereby until payment in full of all obligations guaranteed hereby. 

(g) As between such Guaranteeing Subsidiary, on the one hand, and the Holders and the Trustee, on the other hand,
(x) the maturity of the obligations guaranteed hereby may be accelerated as provided in Article 6 of the Indenture for the purposes of this Guarantee, notwithstanding any stay, injunction or other prohibition preventing such acceleration in
respect of the obligations guaranteed hereby, and (y) in the event of any declaration of acceleration of such obligations as provided in Article 6 of the Indenture, such obligations (whether or not due and payable) shall forthwith become due
and payable by such Guaranteeing Subsidiary for the purpose of this Guarantee. 
 (h) Such Guaranteeing
Subsidiary shall have the right to seek contribution from any non-paying Guarantor so long as the exercise of such right does not impair the rights of the Holders under this Guarantee. 

(i) Pursuant to Section 11.02 of the Indenture, after giving effect to all other contingent and fixed liabilities
that are relevant under any applicable Bankruptcy Law or fraudulent conveyance laws, and after giving effect to any collections from, rights to receive contribution from or payments made by or on behalf of any other Guarantor in respect of the
obligations of such other Guarantor under Article 11 of the Indenture, this new Guarantee shall be 

 
limited to the maximum amount permissible such that the obligations of such Guaranteeing Subsidiary under this Guarantee will not constitute a fraudulent transfer or conveyance. 

(j) This Guarantee shall remain in full force and effect and continue to be effective should any petition be filed by or
against the Company for liquidation, reorganization, should the Company become insolvent or make an assignment for the benefit of creditors or should a receiver or trustee be appointed for all or any significant part of the Company’s assets,
and shall, to the fullest extent permitted by law, continue to be effective or be reinstated, as the case may be, if at any time payment and performance of the Notes are, pursuant to applicable law, rescinded or reduced in amount, or must otherwise
be restored or returned by any obligee on the Notes and Guarantee, whether as a “voidable preference”, “fraudulent transfer” or otherwise, all as though such payment or performance had not been made. In the event that any payment
or any part thereof, is rescinded, reduced, restored or returned, the Note shall, to the fullest extent permitted by law, be reinstated and deemed reduced only by such amount paid and not so rescinded, reduced, restored or returned. 

(k) In case any provision of this Guarantee shall be invalid, illegal or unenforceable, the validity, legality, and
enforceability of the remaining provisions shall not in any way be affected or impaired thereby. 
 (l) This
Guarantee shall be a general senior secured obligation of such Guaranteeing Subsidiary, ranking pari passu with any other future Senior Indebtedness of such Guaranteeing Subsidiary, if any, and senior in right of payment to all existing and
future Subordinated Indebtedness of such Guaranteeing Subsidiary. 
 (m) Each payment to be made by such
Guaranteeing Subsidiary in respect of this Guarantee shall be made without set-off, counterclaim, reduction or diminution of any kind or nature. 

(3) Execution and Delivery. Each Guaranteeing Subsidiary agrees that the Guarantee shall remain in full force and effect
notwithstanding the absence of the endorsement of any notation of such Guarantee on the Notes. 
 (4) Merger, Consolidation
or Sale of All or Substantially All Assets. 
 (a) Except as otherwise provided in Section 5.01(c) of
the Indenture, each Guaranteeing Subsidiary may not consolidate or merge with or into or wind up into (whether or not the Company or such Guaranteeing Subsidiary is the surviving corporation), or sell, assign, transfer, lease, convey or otherwise
dispose of all or substantially all of its properties or assets, in one or more related transactions, to any Person unless: 

(i) (A) such Guaranteeing Subsidiary is the surviving corporation or the Person formed by or surviving any such
consolidation or merger (if other than such Guaranteeing Subsidiary) or to which such sale, assignment, transfer, lease, conveyance or other disposition will have been made is a corporation, partnership, trust or limited liability company organized
or existing under the laws of the jurisdiction of organization of such Guaranteeing Subsidiary, as the case may be, or the laws of the United States, any state thereof, the District of Columbia, or any territory thereof (such Guaranteeing Subsidiary
or such Person, as the case may be, being herein called the “Successor Person”); 

 (B) the Successor Person, if other than such Guaranteeing Subsidiary,
expressly assumes all the obligations of such Guaranteeing Subsidiary under the Indenture, such Guaranteeing Subsidiary’s related Guarantee and the Collateral Documents pursuant to supplemental indentures or other documents or instruments in
form reasonably satisfactory to the Trustee; 
 (C) immediately after such transaction, no Default or Event of
Default exists; 
 (D) the Company shall have delivered to the Trustee an Officer’s Certificate and an
Opinion of Counsel, each stating that such consolidation, merger or transfer and such supplemental indentures, if any, comply with the Indenture; 

(E) the Collateral transferred to the Successor Person shall (i) continue to constitute Collateral under the
Indenture and the Collateral Documents, (ii) be subject to the Lien in favor of the Trustee for the benefit of the holders of the Notes, and (iii) not be subject to any Lien, other than Liens permitted by the terms of the Indenture; and

 (F) to the extent that the assets of the Person which is merged or consolidated with or into the Successor
Person are assets of the type which would constitute Collateral under the Collateral Documents, the Successor Person will take such action as may be reasonably necessary to cause such property and assets to be made subject to the Lien of the
Collateral Documents in the manner and to the extent required in the Indenture; or 
 (ii) the transaction is
made in compliance with Section 4.10 of the Indenture. 
 (b) Subject to certain limitations described in
the Indenture, the Successor Person will succeed to, and be substituted for, such Guaranteeing Subsidiary under the Indenture and such Guaranteeing Subsidiary’s Guarantee. Notwithstanding the foregoing, such Guaranteeing Subsidiary may
(i) merge into or transfer all or part of its properties and assets to another Guarantor or the Company (ii) merge with an Affiliate of the Company solely for the purpose of reincorporating the Guarantor in the United States, any state
thereof, the District of Columbia or any territory thereof or (iii) convert into a corporation, partnership, limited partnership, limited liability company or trust organized under the laws of the jurisdiction of organization of such Guarantor,
in each case without regard to the requirements set forth in Section 5.01(c) of the Indenture. 
 (5) Releases.

 The Guarantee of each Guaranteeing Subsidiary shall be automatically and unconditionally released and discharged, and no
further action by such Guaranteeing Subsidiary, the Company or the Trustee is required for the release of such Guaranteeing Subsidiary’s Guarantee, upon: 

(1) (A) any sale, exchange or transfer (by merger or otherwise) of the Capital Stock of such Guaranteeing Subsidiary after which such
Guaranteeing Subsidiary is no longer a Restricted Subsidiary, if such sale, exchange or transfer is made in compliance with the applicable provisions of the Indenture; 

 (B) the release or discharge of the guarantee by such Guaranteeing
Subsidiary of the ABL Facility or the guarantee which resulted in the creation of the Guarantee, except a discharge or release by or as a result of payment under such guarantee; 

(C) the proper designation of such Guaranteeing Subsidiary as an Unrestricted Subsidiary in accordance with
Section 4.07 of the Indenture and the definition of “Unrestricted Subsidiary” in Section 1.01 of the Indenture; or 

(D) the Company exercising its Legal Defeasance option or Covenant Defeasance option in accordance with Article 8 of the
Indenture or the Company’s obligations under the Indenture being discharged in accordance with the terms of the Indenture; and 

(2) such Guaranteeing Subsidiary delivering to the Trustee an Officer’s Certificate and an Opinion of Counsel, each
stating that all conditions precedent provided for in the Indenture relating to such transaction have been complied with. 
 (6)
No Recourse Against Others. No director, officer, employee, incorporator or stockholder of the Guaranteeing Subsidiaries shall have any liability for any obligations of the Company or the Guarantors (including the Guaranteeing Subsidiaries)
under the Notes, any Guarantees, the Indenture, the Collateral Documents or this Supplemental Indenture or for any claim based on, in respect of, or by reason of, such obligations or their creation. Each Holder by accepting Notes waives and releases
all such liability. The waiver and release are part of the consideration for issuance of the Notes. 
 (7) Governing Law.
THIS SUPPLEMENTAL INDENTURE WILL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK. 
 (8)
Counterparts. The parties may sign any number of copies of this Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement. 

(9) Effect of Headings. The Section headings herein are for convenience only and shall not affect the construction hereof.

 (10) The Trustee. The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or
sufficiency of this Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by each Guaranteeing Subsidiary. 

(11) Subrogation. Each Guaranteeing Subsidiary shall be subrogated to all rights of Holders of Notes against the Company in
respect of any amounts paid by such Guaranteeing Subsidiary pursuant to the provisions of Section 2 hereof and Section 11.01 of the Indenture; provided that, if an Event of Default has occurred and is continuing, such Guaranteeing
Subsidiary shall not be entitled to enforce or receive any payments arising out of, or based upon, such right of subrogation until all amounts then due and payable by the Company under the Indenture or the Notes shall have been paid in full.

 (12) Benefits Acknowledged. Each Guaranteeing Subsidiary’s Guarantee is subject to the terms and conditions set
forth in the Indenture. Each Guaranteeing Subsidiary acknowledges that it will receive direct and indirect benefits from the financing arrangements contemplated by the Indenture and this Supplemental Indenture and that the guarantee and waivers made
by it pursuant to this Guarantee are knowingly made in contemplation of such benefits. 

 (13) Successors. All agreements of each Guaranteeing Subsidiary in this Supplemental
Indenture shall bind its Successors, except as otherwise provided in Section 2(k) hereof or elsewhere in this Supplemental Indenture. All agreements of the Trustee in this Supplemental Indenture shall bind its successors. 

 IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly
executed, all as of the date first above written. 
  

			
	 AHNY DME-LLC

		
	 By:
	 	 /s/ Robert S. Holcombe

	Name:	 	Robert S. Holcombe
	Title:	 	 Executive Vice President, General Counsel

and Secretary

	
	 AHNY-IV LLC

		
	By:	 	 /s/ Robert S. Holcombe

	Name:	 	Robert S. Holcombe
	Title:	 	 Executive Vice President, General Counsel

and Secretary

	
	 U.S. BANK NATIONAL ASSOCIATION, as Trustee

		
	By:	 	 /s/ Raymond S. Haverstock

	Name:	 	Raymond S. Haverstock
	Title:	 	Vice President

 [Second
Supplemental Indenture]Registration Rights Agreement dated as of May 27, 2009

 Exhibit 4.4 

EXECUTION COPY 

REGISTRATION RIGHTS AGREEMENT 

by and among 

Apria Healthcare Group Inc., 

the Guarantors Named Herein 

and 
 Banc of
America Securities LLC 
 Wachovia Capital Markets, LLC 

Barclays Capital Inc. and 

Scotia Capital (USA) Inc. 

Dated as of May 27, 2009 

 This Registration Rights Agreement (this “Agreement”) is made and entered
into as of May 27, 2009, by and among Apria Healthcare Group Inc., a Delaware corporation (the “Issuer”), the Guarantors listed on Schedule A hereto (the “Guarantors”), and Banc of America Securities LLC,
Wachovia Capital Markets, LLC, Barclays Capital Inc. and Scotia Capital (USA) Inc. (collectively, the “Initial Purchasers”), who have agreed to purchase the Issuer’s 11.25% Senior Secured Notes due 2014 (Series A-1) (the
“Initial Series A-1 Notes”) and the related guarantees (the “Initial Guarantees”) pursuant to the Purchase Agreement (as defined below). 

This Agreement is made pursuant to the Purchase Agreement, dated as of May 21, 2009 (the “Purchase Agreement”), by
and among the Issuer, the Guarantors and the Initial Purchasers, (i) for the benefit of the Initial Purchasers and (ii) for the benefit of the holders from time to time of the Series A-1 Notes (as hereinafter defined) (including the
Initial Purchasers). In order to induce the Initial Purchasers to purchase the Initial Series A-1 Notes, the Issuer and the Guarantors have agreed to provide the registration rights set forth in this Agreement. The execution and delivery of this
Agreement is a condition to the obligations of the Initial Purchasers set forth in Section 5(g) of the Purchase Agreement. 
 The parties
hereby agree as follows: 
 SECTION 1. Definitions. As used in this Agreement, the following capitalized terms shall have the
following meanings: 
 Additional Interest: As defined in Section 5 hereof. 

Advice: As defined in the last paragraph of Section 6(c) hereof. 

Agreement: As defined in the preamble hereto. 

Broker-Dealer: Any broker or dealer registered under the Exchange Act. 

Business Day: Any day other than a Saturday, Sunday or U.S. federal holiday or a day on which banking institutions in the City of
New York are authorized or obligated to be closed. 
 Closing Date: The date of this Agreement. 

Commission: The Securities and Exchange Commission. 

Consummate: A Series A-1 Exchange Offer shall be deemed “Consummated” for purposes of this Agreement upon the delivery
by the Issuer to the Registrar under the Indenture of Exchange Series A-1 Notes in the same aggregate principal amount as the aggregate principal amount of Initial Series A-1 Notes that were tendered by Holders thereof pursuant to the Series A-1
Exchange Offer. 
 Effectiveness Period: As defined in Section 4(a) hereof. 

Exchange Act: The Securities Exchange Act of 1934, as amended. 

Exchange Guarantees: The guarantees to be issued by the Guarantors, relating to the Exchange Series A-1 Notes. 

Exchange Series A-1 Notes: The 11.25% Senior Secured Notes due 2014 (Series A-1), of the same series under the Indenture as the
Initial Series A-1 Notes, to be issued to Holders in exchange for Transfer Restricted Securities pursuant to this Agreement. 

 FINRA: The Financial Industry Regulatory Authority 

Holder: As defined in Section 2(b) hereof. 

Indemnified Holder: As defined in Section 8(a) hereof. 

Indenture: The Indenture, dated as of May 27, 2009, among the Issuer, the Guarantors and U.S. Bank National Association, as
trustee (the “Trustee”), pursuant to which the Series A-1 Notes are to be issued, as such Indenture may be amended or supplemented from time to time in accordance with the terms thereof. 

Initial Guarantees: As defined in the preamble hereto. 

Initial Series A-1 Notes: As defined in the preamble hereto. 

Initial Placement Date: The date of the issuance and sale by the Issuer of the Initial Series A-1 Notes to the Initial Purchasers
pursuant to the Purchase Agreement. 
 Initial Purchasers: As defined in the preamble hereto. 

Interest Payment Date: As defined in the Indenture and the Series A-1 Notes. 

Person: An individual, partnership, corporation, trust or unincorporated organization, or a government or agency or political
subdivision thereof. 
 Private Exchange: As defined in Section 3(c) hereof. 

Private Exchange Series A-1 Notes: As defined in Section 3(c) hereof. 

Prospectus: The prospectus included in a Registration Statement, as amended or supplemented by any prospectus supplement and by
all other amendments thereto, including post-effective amendments, and all material incorporated by reference into such Prospectus. 

Registration Deadline: The date that is (1) if Series A-2 Notes are issued within 90 days after the Initial Placement Date,
450 days after the last issue date of Series A-2 Notes during such 90 day period, or (2) if the Series A-2 Notes are not issued within 90 days after the Initial Placement Date, 365 days after the last issue date of Series A-2 Notes, but in no
event later than April 28, 2011. 
 Registration Default: As defined in Section 5 hereof. 

Registration Statement: Any registration statement of the Issuer and the Guarantors relating to (a) an offering of Exchange
Series A-1 Notes pursuant to a Series A-1 Exchange Offer or (b) the registration for resale of Transfer Restricted Securities pursuant to the Shelf Registration Statement, which is filed pursuant to the provisions of this Agreement, in each
case, including the Prospectus included therein, all amendments and supplements thereto (including post-effective amendments) and all exhibits and material incorporated by reference therein. 

Securities Act: The Securities Act of 1933, as amended. 

Series A-1 Exchange Offer: The registration by the Issuer and the Guarantors under the Securities Act of the Exchange Series A-1
Notes pursuant to a Registration Statement pursuant to which the Issuer and the Guarantors offer the Holders of all outstanding Transfer Restricted Securities the 

 

 3 

 
opportunity to exchange all such outstanding Transfer Restricted Securities held by such Holders for Exchange Series A-1 Notes and the Exchange Guarantees in an aggregate principal amount equal
to the aggregate principal amount of the Transfer Restricted Securities tendered in such exchange offer by such Holders. 

Series A-1 Exchange Offer Registration Statement: The Registration Statement relating to the Series A-1 Exchange Offer, including
the related Prospectus. 
 Series A-1 Notes: The Initial Series A-1 Notes and the Exchange Series A-1 Notes. 

Series A-2 Notes: Senior Secured Notes due 2014 (Series A-2) and the related guarantees that may be issued pursuant to the
Indenture at the request of the Initial Purchasers. 
 Shelf Registration Statement: As defined in Section 4 hereof.

 Shelf Suspension Period: As defined in Section 4(a) hereof. 

Transfer Restricted Securities: Each Initial Series A-1 Note and the related Initial Guarantees, until the earliest to occur of
(a) the date on which such Initial Series A-1 Note and the related Initial Guarantees are exchanged in the Series A-1 Exchange Offer and entitled to be resold to the public by the Holders thereof without complying with the prospectus delivery
requirements of the Securities Act, (b) the date on which such Initial Series A-1 Note and the related Initial Guarantees have been effectively registered under the Securities Act and disposed of in accordance with a Shelf Registration
Statement, and (c) the date on which such Initial Series A-1 Note and the related Initial Guarantees are distributed to the public pursuant to Rule 144 under the Securities Act or by a Broker-Dealer pursuant to the “Plan of
Distribution” contemplated by the Series A-1 Exchange Offer Registration Statement (including delivery of the Prospectus contained therein). 

Trust Indenture Act: The Trust Indenture Act of 1939 (15 U.S.C. Sections 77aaa - 77bbbb) as in effect on the date of the
Indenture. 
 Underwritten Registration or Underwritten Offering: A registration in which securities of the Issuer are
sold to an underwriter for reoffering to the public. 
 SECTION 2. Securities Subject to This Agreement. 

(a) Transfer Restricted Securities. The securities entitled to the benefits of this Agreement are the
Transfer Restricted Securities. 
 (b) Holders of Transfer Restricted Securities. A Person is
deemed to be a holder of Transfer Restricted Securities (each, a “Holder”) whenever such Person owns Transfer Restricted Securities. 

SECTION 3. Registered Exchange Offer. 

(a) Unless the Series A-1 Exchange Offer shall not be permissible under applicable law or Commission policy (after the
procedures set forth in Section 6(a) below have been complied with), the Issuer and the Guarantors shall (i) prepare and file with the Commission a Series A-1 Exchange Offer Registration Statement under the Securities Act, (ii) use
their reasonable efforts to cause such Series A-1 Exchange Offer Registration Statement to become effective under the Securities Act, (iii) in connection with the foregoing, file (A) all pre-effective

  

 4 

 
amendments to such Registration Statement as may be necessary in order to cause such Registration Statement to become effective, (B) if applicable, a post-effective amendment to such
Registration Statement pursuant to Rule 430A under the Securities Act and (C) all necessary filings in connection with the registration and qualification of the Exchange Series A-1 Notes to be made under the Blue Sky laws of such jurisdictions
as are necessary to permit Consummation of the Series A-1 Exchange Offer, and (iv) upon the effectiveness of such Registration Statement, commence the Series A-1 Exchange Offer. The Series A-1 Exchange Offer shall be on the appropriate form
permitting registration of the Exchange Series A-1 Notes to be offered in exchange for the Transfer Restricted Securities and to permit resales of Series A-1 Notes held by Broker-Dealers as contemplated by Section 3(c) below. 

(b) The Issuer and the Guarantors shall use their reasonable best efforts to cause the Series A-1 Exchange Offer
Registration Statement to be effective continuously and shall keep the Series A-1 Exchange Offer open for a period of not less than the minimum period required under applicable federal and state securities laws to Consummate the Series A-1 Exchange
Offer; provided, however, that in no event shall such period be less than 20 Business Days after the date notice of the Series A-1 Exchange Offer is mailed to the Holders. The Issuer and the Guarantors shall cause the Series A-1
Exchange Offer to comply with all applicable federal and state securities laws. No securities other than the Series A-1 Notes and, at the Issuer’s option, the Series A-2 Notes shall be included in the Series A-1 Exchange Offer Registration
Statement. The Issuer and the Guarantors shall use commercially reasonable efforts to cause the Series A-1 Exchange Offer to be Consummated on or before the Registration Deadline. 

(c) If, prior to consummation of the Series A-1 Exchange Offer, the Initial Purchasers hold any Initial Series A-1 Notes
acquired by them that have the status of an unsold allotment in the initial distribution, the Issuer, upon the request of the Initial Purchasers, shall simultaneously with the delivery of the Exchange Series A-1 Notes issue and deliver to the
Initial Purchasers, in exchange (the “Private Exchange”) for such Initial Series A-1 Notes held by any such Holder, a like principal amount of notes (the “Private Exchange Series A-1 Notes”) of the Issuer,
guaranteed by the Guarantors, that are identical in all material respects to the Exchange Series A-1 Notes except for the placement of a restrictive legend on such Private Exchange Series A-1 Notes. The Private Exchange Series A-1 Notes shall be
issued pursuant to the same indenture as the Exchange Series A-1 Notes and bear the same CUSIP number as the Exchange Series A-1 Notes if permitted by the CUSIP Service Bureau. 

(d) The Issuer shall indicate in a “Plan of Distribution” section contained in the Prospectus forming a part of
the Series A-1 Exchange Offer Registration Statement that any Broker-Dealer who holds Initial Series A-1 Notes that are Transfer Restricted Securities and that were acquired for its own account as a result of market-making activities or other
trading activities (other than Transfer Restricted Securities acquired directly from the Issuer), may exchange such Initial Series A-1 Notes pursuant to the Series A-1 Exchange Offer; however, such Broker-Dealer may be deemed to be an
“underwriter” within the meaning of the Securities Act and must, therefore, deliver a prospectus meeting the requirements of the Securities Act in connection with any resales of the Exchange Series A-1 Notes received by such Broker-Dealer
in the Series A-1 Exchange Offer, which prospectus delivery requirement may be satisfied by the delivery by such Broker-Dealer of the Prospectus contained in the Series A-1 Exchange Offer Registration Statement. Such “Plan of Distribution”
section shall also contain all other information with respect to such resales by Broker-Dealers that the Commission may require in order to permit such resales pursuant thereto, but such “Plan of Distribution” shall not name any such
Broker-Dealer or disclose the amount of Series A-1 Notes held by any such Broker-Dealer except to the extent required by the Commission as a result of a change in policy after the date of this Agreement. 

 

 5 

 The Issuer and the Guarantors shall use their reasonable best efforts to keep the Series A-1
Exchange Offer Registration Statement continuously effective, supplemented and amended as required by the provisions of Section 6(c) below to the extent necessary to ensure that it is available for resales of Series A-1 Notes acquired by
Broker-Dealers for their own accounts as a result of market-making activities or other trading activities, and to ensure that it conforms with the requirements of this Agreement, the Securities Act and the policies, rules and regulations of the
Commission as announced from time to time, for a period ending on the earlier of (i) 90 days from the date on which the Series A-1 Exchange Offer Registration Statement is declared effective, (ii) the date on which a Broker-Dealer is no
longer required to deliver a prospectus in connection with market-making or other trading activities and (iii) the date on which all the Series A-1 Notes covered by such Series A-1 Exchange Offer Registration Statement have been sold pursuant
to such Series A-1 Exchange Offer Registration Statement. 
 The Issuer shall provide sufficient copies of the latest version of
such Prospectus to Broker-Dealers promptly upon request at any time during such 90-day (or shorter as provided in the foregoing sentence) period in order to facilitate such resales. 

SECTION 4. Shelf Registration. 

(a) Shelf Registration. If (1) because of any change in law or in currently prevailing interpretations
of the staff of the Commission, the Issuer is not permitted to effect the Series A-1 Exchange Offer, (2) the Series A-1 Exchange Offer is not Consummated on or before the Registration Deadline, (3) any holder of Private Exchange Notes so
requests in writing to the Issuer at any time within 30 days after the consummation of the Exchange Offer, or (4) in the case of any Holder that participates in the Series A-1 Exchange Offer, such Holder does not receive Exchange Securities on
or before the date of the exchange that may be sold without restriction under state and federal securities laws (other than due solely to the status of such Holder as an affiliate of the Issuer within the meaning of the Securities Act) and so
notifies the Issuer within 30 days after such Holder first becomes aware of such restrictions, in the case of each of clauses (1) to and including clause (3) of this sentence, then, upon such Holder’s request, the Issuer and the
Guarantors shall (unless the Series A-1 Notes are eligible for resale under Rule 144, without regard to volume, manner of sale or other restrictions contained in Rule 144 under the Securities Act (or any successor rule)): 

(x) use their reasonable best efforts to file a shelf registration statement pursuant to Rule 415 under the Securities Act, which may be
an amendment to the Series A-1 Exchange Offer Registration Statement (in either event, the “Shelf Registration Statement”) as soon as practicable after the filing obligation arises, which Shelf Registration Statement shall provide
for resales of all Transfer Restricted Securities the Holders of which shall have provided the information required pursuant to Section 4(b) hereof; and 

(y) use commercially reasonable efforts to cause such Shelf Registration Statement to be declared effective promptly by the Commission.

 The Issuer and the Guarantors shall use their reasonable best efforts to keep such Shelf Registration Statement continuously
effective, supplemented and amended as required by the provisions of Sections 6(b) and (c) hereof to the extent necessary to ensure that it is available for resales of Series A-1 Notes by the Holders of Transfer Restricted Securities entitled
to the benefit of this Section 4(a), and to ensure that it conforms with the requirements of this Agreement, the Securities Act and the policies, rules 

 

 6 

 
and regulations of the Commission as announced from time to time, until the earliest of (i) two years after the Initial Placement Date of the Initial Series A-1 Notes, (ii) such time as
all of the Initial Series A-1 Notes have been sold thereunder or (iii) the date upon which all Initial Series A-1 Notes covered by such Shelf Registration Statement become eligible for resale under Rule 144, without regard to volume, manner of
sale or other restrictions contained in Rule 144 under the Securities Act (or any successor rule) (the “Effectiveness Period”). 

Notwithstanding anything to the contrary in this Agreement, at any time, the Issuer may delay the filing of any Shelf Registration
Statement or delay or suspend the effectiveness thereof, for a reasonable period of time, but not in excess of 60 consecutive days or more than three (3) times during any calendar year (each, a “Shelf Suspension Period”), if
the Board of Directors of the Company determines reasonably and in good faith that the filing of any such Initial Shelf Registration Statement or the continuing effectiveness thereof would require the disclosure of non-public material information
that, in the reasonable judgment of the Board of Directors of the Company, would be detrimental to the Issuer if so disclosed or would otherwise materially adversely affect a financing, acquisition, disposition, merger or other material transaction
or such action is required by applicable law. 
 (b) Provision by Holders of Certain Information in
Connection with the Shelf Registration Statement. No Holder of Transfer Restricted Securities may include any of its Transfer Restricted Securities in any Shelf Registration Statement pursuant to this Agreement unless and until such Holder
furnishes to the Issuer in writing, within 20 Business Days after receipt of a request therefor, such information as the Issuer may reasonably request for use in connection with any Shelf Registration Statement or Prospectus or preliminary
Prospectus included therein. Each Holder as to which any Shelf Registration Statement is being effected agrees to furnish promptly to the Issuer all information required to be disclosed in order to make the information previously furnished to the
Issuer by such Holder not materially misleading. 
 SECTION 5. Additional Interest. 

If (a) the Series A-1 Exchange Offer has not been Consummated or a Shelf Registration Statement has not been declared effective by
the Commission on or prior to the Registration Deadline, or (b) if applicable, a Shelf Registration Statement has been declared effective but shall thereafter cease to be effective during the Effectiveness Period (other than because of the sale
of all of the Transfer Restricted Securities registered thereunder) (each such event referred to in clauses (a) and (b), a “Registration Default”), then additional interest (“Additional Interest”) shall accrue
on the principal amount of the Series A-1 Notes at a rate of 0.25% per annum during the 90-day period immediately following the occurrence of any Registration Default (which rate will be increased by an additional 0.25% per annum for each
subsequent 90-day period that such Additional Interest continues to accrue; provided that the rate which such Additional Interest accrues may in no event exceed 1.00% per annum) (such Additional Interest to be calculated by the Issuer)
commencing on the (x) first day after the Registration Deadline, in the case of clause (a) above, or (y) the day such Shelf Registration ceases to be effective in the case of clause (b) above; provided, however,
that upon the exchange of the Exchange Series A-1 Notes for all Transfer Restricted Securities tendered, or upon the effectiveness of the applicable Shelf Registration Statement which had ceased to remain effective, Additional Interest on the Series
A-1 Notes in respect of which such events relate as a result of such clause (or the relevant subclause thereof), as the case may be, shall cease to accrue. Notwithstanding any other provisions of this Section 5, the Issuer shall not be
obligated to pay Additional Interest provided in this Section 5 during a Shelf Suspension Period permitted by Section 4(a) hereof. 
  

 7 

 SECTION 6. Registration Procedures. 

(a) Series A-1 Exchange Offer Registration Statement. In connection with the Series A-1 Exchange Offer, the Issuer
and each of the Guarantors shall comply with all of the provisions of Section 6(c) below, shall use their best efforts to effect such exchange to permit the sale of Transfer Restricted Securities being sold in accordance with the intended
method or methods of distribution thereof, and shall comply with all of the following provisions: 
 (i) If in
the reasonable opinion of counsel to the Issuer there is a question as to whether the Series A-1 Exchange Offer is permitted by applicable law and it is advisable to do so, the Issuer and the Guarantors hereby agree to seek a no-action letter or
other favorable decision from the Commission allowing the Issuer and the Guarantors to Consummate a Series A-1 Exchange Offer for such Initial Series A-1 Notes. The Issuer and the Guarantors each hereby agree to pursue the issuance of such a
decision to the Commission staff level but shall not be required to take action to effect a change of Commission policy. The Issuer and the Guarantors each hereby agree, however, to (A) participate in telephonic conferences with the Commission,
(B) deliver to the Commission staff an analysis prepared by counsel to the Issuer setting forth the legal bases, if any, upon which such counsel has concluded that such a Series A-1 Exchange Offer should be permitted and (C) diligently
pursue a resolution by the Commission staff of such submission. 
 (ii) As a condition to its participation in
the Series A-1 Exchange Offer pursuant to the terms of this Agreement, each Holder of Transfer Restricted Securities shall furnish, upon the request of the Issuer, prior to the Consummation thereof, a written representation to the Issuer (which may
be contained in the letter of transmittal contemplated by the Series A-1 Exchange Offer Registration Statement) to the effect that (A) it is not an affiliate of the Issuer, (B) it is not engaged in, and does not intend to engage in, and
has no arrangement or understanding with any person to participate in, a distribution of the Exchange Series A-1 Notes to be issued in the Series A-1 Exchange Offer and (C) it is acquiring the Exchange Series A-1 Notes in its ordinary course of
business. In addition, all such Holders of Transfer Restricted Securities shall otherwise cooperate in the Issuer’s preparations for the Series A-1 Exchange Offer. Each Holder, including any Holder that is a Broker-Dealer, shall acknowledge and
agree that any such Holder using the Series A-1 Exchange Offer to participate in a distribution of the securities to be acquired in the Series A-1 Exchange Offer (1) could not under Commission policy as in effect on the date of this Agreement
rely on the position of the Commission enunciated in Morgan Stanley & Co., Inc. (available June 5, 1991) and Exxon Capital Holdings Corporation (available May 13, 1988), as interpreted in the Commission’s letter to
Shearman & Sterling dated July 2, 1993, and similar no-action letters (which may include any no-action letter obtained pursuant to clause (i) above), and (2) must comply with the registration and prospectus delivery
requirements of the Securities Act in connection with a secondary resale transaction and that such a secondary resale transaction should be covered by an effective registration statement containing the selling security holder information required by
Item 507 or 508, as applicable, of Regulation S-K if the resales are of Exchange Series A-1 Notes obtained by such Holder in exchange for Initial Series A-1 Notes acquired by such Holder directly from the Issuer. 

 

 8 

 (b) Shelf Registration Statement. In connection with the Shelf
Registration Statement, the Issuer and each of the Guarantors shall comply with all the provisions of Section 6(c) below. 

(c) General Provisions. In connection with any Registration Statement and any Prospectus required by this
Agreement to permit the sale or resale of Transfer Restricted Securities (including, without limitation, any Registration Statement and the related Prospectus required to permit resales of Series A-1 Notes by Broker-Dealers), the Issuer and the
Guarantors shall: 
 (i) use their reasonable best efforts to keep such Registration Statement continuously
effective and provide all requisite financial statements including, if required by the Securities Act or any regulation thereunder, financial statements of the Guarantors; upon the occurrence of any event that would cause any such Registration
Statement or the Prospectus contained therein (A) to contain an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein not misleading or (B) not to be effective and usable for resale
of Transfer Restricted Securities during the period required by this Agreement, the Issuer and the Guarantors shall file promptly an appropriate amendment to such Registration Statement or supplement to the Prospectus or document incorporated by
reference, in the case of clause (A), correcting any such misstatement or omission, and, in the case of an amendment, use their reasonable best efforts to cause such amendment to be declared effective and such Registration Statement and the related
Prospectus to become usable for their intended purpose(s) as soon as practicable thereafter; 
 (ii) prepare and
file with the Commission such amendments and post-effective amendments to the Registration Statement as may be necessary to keep the Registration Statement effective for the applicable period set forth in Section 3 or 4 hereof; cause the
Prospectus to be supplemented by any required Prospectus supplement, and as so supplemented to be filed pursuant to Rule 424 under the Securities Act, and to comply fully with the applicable provisions of Rules 424 and 430A under the Securities Act,
as applicable, in a timely manner; and comply with the provisions of the Securities Act with respect to the disposition of all securities covered by such Registration Statement during the applicable period in accordance with the intended method or
methods of distribution by the sellers thereof set forth in such Registration Statement or supplement to the Prospectus; 

(iii) advise the underwriter(s), if any, and selling Holders promptly and, if requested by such Persons, confirm such
advice in writing, (A) when the Prospectus or any Prospectus supplement or post-effective amendment has been filed, and, with respect to any Registration Statement or any post-effective amendment thereto, when the same has become effective,
(B) of any request by the Commission for amendments to the Registration Statement or amendments or supplements to the Prospectus or for additional information relating thereto, (C) of the issuance by the Commission of any stop order
suspending the effectiveness of the Registration Statement under the Securities Act or of the suspension by any state securities commission of the qualification of the Transfer Restricted Securities for offering or sale in any jurisdiction, or the
initiation of any proceeding for any of the preceding purposes, and (D) of the existence of any fact or the happening of any event that makes any statement of a material fact made in the Registration Statement, the Prospectus, any amendment or
supplement thereto, or any document incorporated by reference therein untrue, or that requires the making of any 
  

 9 

 
additions to or changes in the Registration Statement or the Prospectus in order to make the statements therein not misleading. If at any time the Commission shall issue any stop order suspending
the effectiveness of the Registration Statement, or any state securities commission or other regulatory authority shall issue an order suspending the qualification or exemption from qualification of the Transfer Restricted Securities under state
securities or Blue Sky laws, the Issuer and the Guarantors shall use their reasonable best efforts to obtain the withdrawal or lifting of such order at the earliest possible time; 

(iv) furnish without charge to counsel for the Initial Purchasers, each selling Holder named in any Registration
Statement, and each of the underwriter(s), if any, at least one copy before filing with the Commission of any Registration Statement or any Prospectus included therein or any amendments or supplements to any such Registration Statement or Prospectus
(including, if requested in writing by any such Person, all documents incorporated by reference after the initial filing of such Registration Statement, if not available on the Commission’s EDGAR database), which Registration Statement or any
Prospectus included therein or any amendments or supplements to any such Registration Statement or Prospectus will be subject to the review of the Initial Purchasers and such Holders and underwriter(s) in connection with such sale, if any, for a
reasonable period, and the Issuer will not file any such Registration Statement or Prospectus or any amendment or supplement to any such Registration Statement or Prospectus to which the Initial Purchasers or the underwriter(s), if any, shall
reasonably object in writing after the receipt thereof (such objection to be deemed timely made upon confirmation of telecopy transmission within such period). The objection of an Initial Purchaser or an underwriter, if any, shall be deemed to be
reasonable if such Registration Statement, amendment, Prospectus or supplement, as applicable, as proposed to be filed, contains an untrue statement of a material fact or omits to state a material fact necessary to make the statements therein not
misleading; 
 (v) make reasonably available for inspection by the Initial Purchasers, any managing underwriter
participating in any disposition pursuant to such Registration Statement and any attorney or accountant retained by such Initial Purchaser or any of the underwriter(s), all material financial and other records, pertinent corporate documents and
properties of the Issuer and the Guarantors and cause the Issuer’s and the Guarantors’ officers and employees to supply all information reasonably requested by any such Holder, underwriter, attorney or accountant in connection with such
Registration Statement subsequent to the filing thereof and prior to its effectiveness, in each case, as shall be reasonably necessary to enable such persons to conduct an investigation within the meaning of Section 11 of the Securities Act;
provided, however, (A) that the foregoing inspection and information gathering shall be coordinated on behalf of the Initial Purchasers by Fried, Frank, Harris, Shriver & Jacobson LLP and on behalf of any other parties by
one counsel designated by and on behalf of such other parties as described in Section 7 hereof, and (B) that any information that is reasonably and in good faith designated by the Issuer in writing as confidential at the time of delivery
of such information shall be kept confidential by the Initial Purchasers, the Holders, or any such underwriter, attorney, accountant or other agent, unless (1) disclosure of such information is required by court or administrative order or is
necessary to respond to inquiries of regulatory authorities, (2) disclosure of such information is required by law (including any disclosure requirements pursuant to federal securities laws in connection with the filing of such Registration
Statement or the use of any Prospectus), (3) such information becomes generally available to the public other than as a result of a disclosure or failure to safeguard such information by such person or (4) such information becomes
available 
  

 10 

 
to such Initial Purchaser, Holder, underwriter, attorney, accountant or other agent from a source other than the Issuer and such source is not known, after due inquiry, by the relevant Initial
Purchaser, Holder, underwriter, attorney, accountant or other agent to be bound by a confidentiality agreement or is not otherwise under a duty of trust to the Issuer. 

(vi) if requested in writing by any selling Holders or the underwriter(s), if any, promptly incorporate in any
Registration Statement or Prospectus, pursuant to a supplement or post-effective amendment if necessary, such information as such selling Holders and underwriter(s), if any, may reasonably request to have included therein, including, without
limitation, information relating to the “Plan of Distribution” of the Transfer Restricted Securities, information with respect to the principal amount of Transfer Restricted Securities being sold to such underwriter(s), the purchase price
being paid therefor and any other terms of the offering of the Transfer Restricted Securities to be sold in such offering; and make all required filings of such Prospectus supplement or post-effective amendment as soon as practicable after the
Issuer is notified of the matters to be incorporated in such Prospectus supplement or post-effective amendment; 

(vii) use commercially reasonable efforts to confirm that the ratings assigned to the Initial Series A-1 Notes will apply
to the Transfer Restricted Securities covered by the Registration Statement, if so requested by the Holders of a majority in aggregate principal amount of Series A-1 Notes covered thereby or the underwriter(s), if any; 

(viii) furnish to each selling Holder and each of the underwriter(s), if any, without charge, at least one copy of the
Registration Statement, as first filed with the Commission, and of each amendment thereto, including financial statements and schedules and, if requested in writing, all documents incorporated by reference therein and all exhibits (including
exhibits incorporated therein by reference); 
 (ix) deliver to each selling Holder and each of the
underwriter(s), if any, without charge, as many copies of the Prospectus (including each preliminary prospectus) and any amendment or supplement thereto as such Persons reasonably may request; the Issuer and the Guarantors hereby consent to the use
of the Prospectus and any amendment or supplement thereto by each of the selling Holders and each of the underwriter(s), if any, in connection with the offering and the sale of the Transfer Restricted Securities covered by the Prospectus or any
amendment or supplement thereto; 
 (x) enter into such agreements (including an underwriting agreement), make
such representations and warranties, and take all such other actions in connection therewith in order to expedite or facilitate the disposition of the Transfer Restricted Securities pursuant to any Shelf Registration Statement contemplated by this
Agreement, all to such extent as may be reasonably requested by an Initial Purchaser or by any Holder of Transfer Restricted Securities or underwriter in connection with any sale or resale pursuant to any Shelf Registration Statement contemplated by
this Agreement; and, whether or not an underwriting agreement is entered into and whether or not such registration is an Underwritten Registration, the Issuer and the Guarantors shall: 

(A) furnish to the Initial Purchasers, each selling Holder and each underwriter, if any, in such substance and scope as
they may request and as are customarily made by issuers to underwriters in primary underwritten offerings, upon the date of the effectiveness of the Shelf Registration Statement: 

(1) a certificate, dated the date of the effectiveness of the Shelf Registration Statement signed by (y) the
President or any Vice President and (z) a principal financial or accounting officer of the Issuer, confirming, as of the date thereof, the matters set forth in paragraphs (i), (ii) and (iii) of Section 5(f) of the Purchase
Agreement and such other matters as such parties may reasonably request; 
  

 11 

 (2) an opinion, dated the date of the effectiveness of the Shelf
Registration Statement of counsel for the Issuer and the Guarantors, in form, scope and substance reasonably satisfactory to the managing underwriter, addressed to the underwriters covering the matters customarily covered in opinions, reasonably
requested in underwritten offerings, and in any event including a statement to the effect that such counsel has participated in conferences with officers and other representatives of the Issuer and the Guarantors, representatives of the independent
public accountants for the Issuer and the Guarantors, the Initial Purchasers’ representatives and the Initial Purchasers’ counsel in connection with the preparation of such Registration Statement and the related Prospectus and have
considered the matters required to be stated therein and the statements contained therein, although such counsel has not independently verified the accuracy, completeness or fairness of such statements; and that such counsel advises that, on the
basis of the foregoing (relying as to materiality to a large extent upon facts provided to such counsel by officers and other representatives of the Issuer and the Guarantors and without independent check or verification), no facts came to such
counsel’s attention that caused such counsel to believe that the Shelf Registration Statement, at the time such Registration Statement or any post-effective amendment thereto became effective contained an untrue statement of a material fact or
omitted to state a material fact required to be stated therein or necessary to make the statements therein not misleading, or that the Prospectus contained in such Registration Statement as of its date contained an untrue statement of a material
fact or omitted to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. Without limiting the foregoing, such counsel may state further that such counsel
assumes no responsibility for, and has not independently verified, the accuracy, completeness or fairness of the financial statements, notes and schedules and other financial data included in any Registration Statement contemplated by this Agreement
or the related Prospectus; and 
 (3) customary comfort letters, dated as of the date of the effectiveness of
the Shelf Registration Statement in form, scope and substance reasonably satisfactory to the managing underwriter from (a) the Issuer’s and the Guarantors’ independent accountants and (b) the independent accountants of any other
Person for which financial statements are included in or incorporated by reference in to such Shelf Registration Statement, in the customary form and covering matters of the type customarily covered in comfort letters by underwriters in connection
with primary underwritten offerings; 
  

 12 

 (B) set forth in full or incorporate by reference in the underwriting
agreement, if any, the indemnification provisions and procedures of Section 8 hereof with respect to all parties to be indemnified pursuant to said Section; and 

(C) deliver such other documents and certificates as may be reasonably requested by such parties to evidence compliance
with clause (A) above and with any customary conditions contained in the underwriting agreement or other agreement entered into by the Issuer or the Guarantors pursuant to this clause (x), if any. 

If at any time the representations and warranties of the Issuer and the Guarantors contemplated in clause (A)(1) above cease to be true
and correct, the Issuer or the Guarantors shall so advise the Initial Purchasers and the underwriter(s), if any, and each selling Holder promptly and, if requested by such Persons, shall confirm such advice in writing; 

(xi) prior to any public offering of Transfer Restricted Securities, cooperate with the selling Holders, the
underwriter(s), if any, and their respective counsel in connection with the registration and qualification of the Transfer Restricted Securities under the securities or Blue Sky laws of such jurisdictions as the selling Holders or underwriter(s) may
reasonably request and do any and all other acts or things necessary or advisable to enable the disposition in such jurisdictions of the Transfer Restricted Securities covered by the Shelf Registration Statement; provided, however, that
neither the Issuer nor the Guarantors shall be required to register or qualify as a foreign corporation where it is not then so qualified or to take any action that would subject it to the service of process in suits or to taxation, other than as to
matters and transactions relating to the Registration Statement, in any jurisdiction where it is not then so subject; 

(xii) shall issue, upon the request of any Holder of Initial Series A-1 Notes covered by and sold pursuant to the Shelf
Registration Statement, Exchange Series A-1 Notes, having an aggregate principal amount equal to the aggregate principal amount of Initial Series A-1 Notes surrendered to the Issuer by such Holder in exchange therefor; such Exchange Series A-1 Notes
to be registered in the name of the purchaser of such Series A-1 Notes; in return, the Initial Series A-1 Notes held by such Holder shall be surrendered to the Issuer for cancellation; 

(xiii) cooperate with the selling Holders and the underwriter(s), if any, to facilitate the timely preparation and
delivery of certificates representing Transfer Restricted Securities to be sold and not bearing any restrictive legends; and enable such Transfer Restricted Securities to be in such denominations and registered in such names as the Holders or the
underwriter(s), if any, may request at least two Business Days prior to any sale of Transfer Restricted Securities made by such underwriter(s); 

(xiv) use commercially reasonable efforts to cause the Transfer Restricted Securities covered by the Registration
Statement to be registered with or approved by such other governmental agencies or authorities as may be necessary to enable the seller or sellers thereof or the underwriter(s), if any, to consummate the disposition of such Transfer Restricted
Securities, subject to the proviso contained in clause (xi) above; 
 (xv) if any fact or event contemplated
by clause (c)(iii)(D) above shall exist or have occurred, prepare a supplement or post-effective amendment to the Registration 

 

 13 

 
Statement or related Prospectus or any document incorporated therein by reference or file any other required document so that, as thereafter delivered to the purchasers of Transfer Restricted
Securities, the Prospectus will not contain an untrue statement of a material fact or omit to state any material fact necessary to make the statements therein not misleading; 

(xvi) provide a CUSIP number for all Transfer Restricted Securities not later than the effective date of the Registration
Statement and provide the Trustee under the Indenture with printed certificates for the Transfer Restricted Securities which are in a form eligible for deposit with the Depository Trust Company; 

(xvii) cooperate and assist in any filings required to be made with the FINRA and in the performance of any due diligence
investigation by any underwriter (including any “qualified independent underwriter”) that is required to be retained in accordance with the rules and regulations of the FINRA, and use their reasonable best efforts to cause such
Registration Statement to become effective and approved by such governmental agencies or authorities as may be necessary to enable the Holders selling Transfer Restricted Securities to consummate the disposition of such Transfer Restricted
Securities; 
 (xviii) otherwise use their reasonable best efforts to comply with all applicable rules and
regulations of the Commission, and make generally available to the Issuer’s security holders, as soon as practicable, a consolidated earnings statement meeting the requirements of Rule 158 (which need not be audited) for the twelve-month period
(A) commencing at the end of any fiscal quarter in which Transfer Restricted Securities are sold to underwriters in a firm or best efforts underwritten offering or (B) if not sold to underwriters in such an offering, beginning with the
first month of the Issuer’s first fiscal quarter commencing after the effective date of the Registration Statement; 

(xix) cause the Indenture to be qualified under the Trust Indenture Act not later than the effective date of the first
Registration Statement required by this Agreement, and, in connection therewith, cooperate with, and cause the Guarantors to cooperate with, the Trustee and the Holders of Series A-1 Notes to effect such changes to the Indenture as may be required
for such Indenture to be so qualified in accordance with the terms of the Trust Indenture Act; and to execute, and cause the Guarantors to execute, and use their reasonable best efforts to cause the Trustee to execute, all documents that may be
required to effect such changes and all other forms and documents required to be filed with the Commission to enable such Indenture to be so qualified in a timely manner; and 

(xx) provide promptly to each Holder upon request each document filed with the Commission pursuant to the requirements of
Section 13 and Section 15 of the Exchange Act. 
 Each Holder shall agree by acquisition of a Transfer Restricted
Security that, upon receipt of any notice from the Issuer of the existence of any fact of the kind described in Section 6(c)(iii)(D) hereof, such Holder will forthwith discontinue disposition of Transfer Restricted Securities pursuant to the
applicable Registration Statement until such Holder’s receipt of the copies of the supplemented or amended Prospectus contemplated by Section 6(c)(xv) hereof, or until it is advised in writing (the “Advice”) by the Issuer
that the use of the Prospectus may be resumed, and has received copies of any additional or supplemental filings that are incorporated by reference in the Prospectus. If so directed by 

 

 14 

 
the Issuer, each Holder will deliver to the Issuer (at the Issuer’s expense) all copies, other than permanent file copies then in such Holder’s possession, of the Prospectus covering
such Transfer Restricted Securities that was current at the time of receipt of such notice. In the event the Issuer shall give any such notice, the time period regarding the effectiveness of such Registration Statement set forth in Section 3 or
4 hereof, as applicable, shall be extended by the number of days during the period from and including the date of the giving of such notice pursuant to Section 6(c)(iii)(D) hereof to and including the date when each selling Holder covered by
such Registration Statement shall have received the copies of the supplemented or amended Prospectus contemplated by Section 6(c)(xv) hereof or shall have received the Advice; however, no such extension shall be taken into account in
determining whether Additional Interest is due pursuant to Section 5 hereof or the amount of such Additional Interest. 
 SECTION 7.
Registration Expenses. 
 (a) All expenses incident to the Issuer’s or the Guarantors’
performance of or compliance with this Agreement will be borne by the Issuer and the Guarantors, regardless of whether a Registration Statement becomes effective, including without limitation: (i) all registration and filing fees and expenses
(including filings made by the Initial Purchasers or Holders with the FINRA (and, if applicable, the fees and expenses of any “qualified independent underwriter” and its counsel that may be required by the rules and regulations of the
FINRA)); (ii) all fees and expenses of compliance with federal securities and state Blue Sky or securities laws; (iii) all expenses of printing (including printing of Prospectuses), messenger and delivery services and telephone;
(iv) all fees and disbursements of counsel for the Issuer, the Guarantors and, subject to Section 7(b) below, the Holders of Transfer Restricted Securities; (v) all fees and disbursements of independent certified public accountants of
the Issuer and the Guarantors (including the expenses of any special audit and comfort letters required by or incident to such performance); and (vi) all fees and expenses of the trustee and the exchange agent and their counsel. 

The Issuer and the Guarantors will, in any event, bear their internal expenses (including, without limitation, all
salaries and expenses of its officers and employees performing legal or accounting duties), the expenses of any annual audit and the fees and expenses of any Person, including special experts, retained by the Issuer or the Guarantors. 

(b) In connection with any Shelf Registration Statement required by this Agreement, the Issuer and the Guarantors will
reimburse the Initial Purchasers and the Holders of Transfer Restricted Securities being registered pursuant to the Shelf Registration Statement, as applicable, for the reasonable fees and disbursements of not more than one counsel, who shall be
Fried, Frank, Harris, Shriver & Jacobson LLP or such other counsel as may be chosen by the Holders of a majority in principal amount of the Transfer Restricted Securities for whose benefit such Shelf Registration Statement is being
prepared. 
 SECTION 8. Indemnification. 

(a) The Issuer agrees and the Guarantors, jointly and severally, agree to indemnify and hold harmless (i) each Holder
and (ii) each person, if any, who controls (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) any Holder (any of the persons referred to in this clause (ii) being hereinafter referred to as
a “controlling person”) and (iii) the respective officers, directors, partners, employees, representatives and agents of any Holder or any controlling person (any person referred to in clause (i), (ii) or (iii) may
hereinafter be referred to as an “Indemnified Holder”), to the fullest extent lawful, from and against any and all losses, claims, damages, liabilities, judgments, actions and expenses (including without

  

 15 

 
limitation and as incurred, reimbursement of all reasonable costs of investigating, preparing, pursuing, settling, compromising, paying or defending any claim or action, or any investigation or
proceeding by any governmental agency or body, commenced or threatened, including the reasonable fees and expenses of counsel to any Indemnified Holder), joint or several, directly or indirectly caused by, related to, based upon, arising out of or
in connection with any untrue statement or alleged untrue statement of a material fact contained in any Registration Statement or Prospectus (or any amendment or supplement thereto), or any omission or alleged omission to state therein a material
fact required to be stated therein or necessary to make the statements therein not misleading, except insofar as such losses, claims, damages, liabilities or expenses are caused by an untrue statement or omission or alleged untrue statement or
omission that is made in reliance upon and in conformity with information relating to any of the Holders furnished in writing to the Issuer and the Guarantors by any of the Holders expressly for use therein. This indemnity agreement shall be in
addition to any liability which the Issuer or any Guarantor may otherwise have. 
 In case any action or
proceeding (including any governmental or regulatory investigation or proceeding) shall be brought or asserted against any of the Indemnified Holders with respect to which indemnity may be sought against the Issuer or any Guarantor, such Indemnified
Holder (or the Indemnified Holder controlled by such controlling person) shall promptly notify the Issuer and the Guarantors in writing (provided that the failure to give such notice shall not relieve the Issuer or the Guarantors of their
respective obligations pursuant to this Agreement except to the extent they are materially prejudiced as a proximate result of such failure). In case any such action is brought against any Indemnified Holder and such Indemnified Holder seeks or
intends to seek indemnity from the Issuer or the Guarantors, the Issuer or the Guarantors will be entitled to participate in and, to the extent that it shall elect, jointly with all other indemnifying parties similarly notified, by written notice
delivered to the Indemnified Holder promptly after receiving the aforesaid notice from such Indemnified Holder, to assume the defense thereof with counsel reasonably satisfactory to such Indemnified Holder; provided, however, if the
defendants in any such action include both the Indemnified Holder and the Issuer or the Guarantors and the Indemnified Holder shall have reasonably concluded (based on the advice of counsel) that a conflict may arise between the positions of the
Issuer or the Guarantors and the Indemnified Holder in conducting the defense of any such action or that there may be legal defenses available to it and/or other Indemnified Holders which are different from or additional to those available to the
Issuer or the Guarantors, the Indemnified Holder or Holders shall have the right to select separate counsel to assume such legal defenses and to otherwise participate in the defense of such action on behalf of such Indemnified Holder or Holders.
Upon receipt of notice from the Issuer or Guarantors to such Indemnified Holder of the Issuer’s or the Guarantors’ election so to assume the defense of such action and approval by the Indemnified Holder of counsel, the Issuer or the
Guarantors will not be liable to such Indemnified Holder under this Section 8 for any legal or other expenses subsequently incurred by such Indemnified Holder in connection with the defense thereof unless (i) the Indemnified Holder shall
have employed separate counsel in accordance with the proviso to the next preceding sentence (it being understood, however, that the Issuer or the Guarantors shall not be liable for the expenses of more than one separate counsel (together with local
counsel), approved by the Issuer or the Guarantors, representing the Indemnified Holders who are parties to such action) or (ii) the Issuer or the Guarantors shall not have employed counsel satisfactory to the Indemnified Holder to represent
the Indemnified Holder within a reasonable time after notice of commencement of the action, in each of which cases the fees and expenses of counsel shall be at the expense of the Issuer or the Guarantors. It is understood and agreed that the Issuer
or the Guarantors shall not, in connection with any proceeding or related proceeding in the same jurisdiction, be liable for the reasonable fees and expenses of more than one separate firm (together with any local counsel) for all Indemnified

  

 16 

 
Holders. Each Indemnified Holder, as a condition to indemnification hereunder, shall use all reasonable efforts to cooperate with the Issuer or the Guarantors in the defense of any such action or
claim. The Issuer shall not be liable for any settlement of any such action or proceeding effected without the Issuer’s prior written consent, but if settled with such consent or there be a final judgment for the plaintiff, the Issuer and the
Guarantors agree to indemnify and hold harmless any Indemnified Holder from and against any loss, claim, damage, liability or expense by reason of such settlement or judgment. The Issuer and the Guarantors shall not, without the prior written
consent of each Indemnified Holder, settle or compromise or consent to the entry of judgment in or otherwise seek to terminate any pending or threatened action, claim, litigation or proceeding in respect of which indemnification or contribution may
be sought hereunder (whether or not any Indemnified Holder is a party thereto), unless such settlement, compromise, consent or termination includes an unconditional release of each Indemnified Holder from all liability arising out of such action,
claim, litigation or proceeding. 
 (b) Each Holder of Transfer Restricted Securities shall, severally and not
jointly, indemnify and hold harmless the Issuer, the Guarantors and their respective officers, directors, partners, employees, representatives and agents, and any person controlling (within the meaning of Section 15 of the Securities Act or
Section 20 of the Exchange Act) the Issuer and the Guarantors, and the respective officers, directors, partners, employees, representatives and agents of each such person, to the same extent as the foregoing indemnity from the Issuer and the
Guarantors to each of the Indemnified Holders, but only with respect to claims and actions based on information relating to such Holder furnished in writing by such Holder expressly for use in any Registration Statement. In case any action or
proceeding shall be brought against the Issuer, the Guarantors, any such controlling person, or their respective officers, directors, partners, employees, representatives and agents in respect of which indemnity may be sought against a Holder of
Transfer Restricted Securities, such Holder shall have the rights and duties given the Issuer and the Guarantors and the Issuer, the Guarantors, such controlling person and their respective officers, directors, partners, employees, representatives
and agents shall have the rights and duties given to each Indemnified Holder by Section 8(a). In no event shall the liability of any selling Holder hereunder be greater in amount than the dollar amount of the proceeds received by such Holder
upon the sale of the Series A-1 Notes giving rise to such indemnification obligation. 
 (c) If the
indemnification provided for in this Section 8 is unavailable to an indemnified party under Section 8(a) or Section 8(b) hereof (other than by reason of exceptions provided in those Sections, including by reason of failure to notify
the Issuer and the Guarantors of indemnification obligations thereunder to the extent that they are materially prejudiced as a proximate result of such failure) in respect of any losses, claims, damages, liabilities, judgments, actions or expenses
referred to therein, then each applicable indemnifying party, in lieu of indemnifying such indemnified party, shall contribute to the amount paid or payable by such indemnified party as a result of such losses, claims, damages, liabilities or
expenses in such proportion as is appropriate to reflect the relative benefits received by the Issuer and the Guarantors, on the one hand, and the Holders, on the other hand, from the Initial Placement (which in the case of the Issuer shall be
deemed to be equal to the total gross proceeds from the Initial Placement as set forth on the cover page of the Offering Memorandum) or if such allocation is not permitted by applicable law, the relative fault of the Issuer and the Guarantors on the
one hand, and of the Indemnified Holder, on the other hand, in connection with the statements or omissions which resulted in such losses, claims, damages, liabilities or expenses, as well as any other relevant equitable considerations. The relative
fault of the Issuer on the one hand and of the Indemnified Holder on the other shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a
material fact relates to information supplied by the Issuer or by the 
  

 17 

 
Indemnified Holder and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The amount paid or payable by a party
as a result of the losses, claims, damages, liabilities and expenses referred to above shall be deemed to include, subject to the limitations set forth in the second paragraph of Section 8(a), any legal or other fees or expenses reasonably
incurred by such party in connection with investigating or defending any action or claim. 
 The Issuer and the
Guarantors agree and each Holder of Transfer Restricted Securities shall agree that it would not be just and equitable if contribution pursuant to this Section 8(c) were determined by pro rata allocation (even if the Holders were treated as one
entity for such purpose) or by any other method of allocation which does not take account of the equitable considerations referred to in the immediately preceding paragraph. The amount paid or payable by an indemnified party as a result of the
losses, claims, damages, liabilities or expenses referred to in the immediately preceding paragraph shall be deemed to include, subject to the limitations set forth above, any legal or other expenses reasonably incurred by such indemnified party in
connection with investigating or defending any such action or claim. Notwithstanding the provisions of this Section 8, none of the Holders (and its related Indemnified Holders) shall be required to contribute, in the aggregate, any amount in
excess of the amount by which the net proceeds received by such Holder from the sale of the Series A-1 Notes pursuant to a Registration Statement exceeds the amount of any damages which such Holder has otherwise been required to pay by reason of
such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not
guilty of such fraudulent misrepresentation. The Holders’ obligations to contribute pursuant to this Section 8(c) are several in proportion to the respective principal amount of Initial Series A-1 Notes held by each of the Holders
hereunder and not joint. 
 SECTION 9. Rule 144A. 

The Issuer and the Guarantors each hereby agrees with each Holder, for so long as any Transfer Restricted Securities remain outstanding,
to make available to any Holder or beneficial owner of Transfer Restricted Securities in connection with any sale thereof and any prospective purchaser of such Transfer Restricted Securities from such Holder or beneficial owner, the information
required by Rule 144A(d)(4) under the Securities Act in order to permit resales of such Transfer Restricted Securities pursuant to Rule 144A. 

SECTION 10. Participation in Underwritten Registrations. 

No Holder may participate in any Underwritten Registration hereunder unless such Holder (a) agrees to sell such Holder’s
Transfer Restricted Securities on the basis provided in any underwriting arrangements approved by the Persons entitled hereunder to approve such arrangements and (b) completes and executes all reasonable questionnaires, powers of attorney,
indemnities, underwriting agreements, lock-up letters and other documents required under the terms of such underwriting arrangements. 
 SECTION
11. Selection of Underwriters. 
 The Holders of Transfer Restricted Securities covered by the Shelf Registration
Statement who desire to do so may sell such Transfer Restricted Securities in an Underwritten Offering. In any such Underwritten Offering, the investment banker or investment bankers and manager or managers that will administer the offering will be
selected by the Holders of a majority in aggregate principal amount of the Transfer Restricted Securities included in such offering; provided that such investment bankers and managers must be reasonably satisfactory to the Issuer. 

 

 18 

 SECTION 12. Miscellaneous. 

(a) Remedies. The Issuer and the Guarantors each hereby agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Agreement and hereby agree to waive the defense in any action for specific performance that a remedy at law would be adequate. 

(b) No Inconsistent Agreements. The Issuer will not, and will cause the Guarantors to not, on or after the date of
this Agreement enter into any agreement with respect to its securities that is inconsistent with the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions hereof. Neither the Issuer nor any of the Guarantors has
entered into any agreement granting any registration rights with respect to its securities to any Person pursuant to which any such Person would have the right to include any securities in any Registration Statement to be filed with the Commission
as required under this Agreement. The rights granted to the Holders hereunder do not in any way conflict with and are not inconsistent with the rights granted to the holders of the Issuer’s securities under any agreement in effect on the date
hereof. 
 (c) Adjustments Affecting the Series A-1 Notes. The Issuer and the Guarantors will not take any
action, or permit any change to occur, with respect to the Series A-1 Notes that would materially and adversely affect their ability to Consummate the Series A-1 Exchange Offer. 

(d) Amendments and Waivers. The provisions of this Agreement may not be amended, modified or supplemented, and
waivers or consents to or departures from the provisions hereof may not be given unless the Issuer has obtained the written consent of Holders of a majority of the outstanding principal amount of Transfer Restricted Securities. Notwithstanding the
foregoing, a waiver or consent to departure from the provisions hereof that relates exclusively to the rights of Holders whose securities are being tendered pursuant to the Series A-1 Exchange Offer and that does not affect directly or indirectly
the rights of other Holders whose securities are not being tendered pursuant to such Series A-1 Exchange Offer may be given by the Holders of a majority of the outstanding principal amount of Transfer Restricted Securities being tendered or
registered; provided that, with respect to any matter that directly or indirectly affects the rights of the Initial Purchasers hereunder, the Issuer shall obtain the written consent of the Initial Purchasers with respect to which such
amendment, qualification, supplement, waiver, consent or departure is to be effective. 
 (e) Notices. All
notices and other communications provided for or permitted hereunder shall be made in writing by hand-delivery, first-class mail (registered or certified, return receipt requested), telex, telecopier, or air courier guaranteeing overnight delivery:

 (i) if to a Holder, at the address set forth on the records of the Registrar under the Indenture, with a copy
to the Registrar under the Indenture; and 
  

 19 

 (ii) If to the Initial Purchasers: 

Banc of America Securities LLC 

One Bryant Park 

New York, New York 10036 

Facsimile: (212) 901-7897 

Attention: Legal Department 

with a copy to: 

Fried, Frank, Harris, Shriver & Jacobson LLP 

One New York Plaza 

New York, New York 10004 

Facsimile: (212) 859-4000 

Attention: Valerie Ford Jacob, Esq. 

If to the Issuer or the Guarantors: 

Apria Healthcare Group Inc. 

26220 Enterprise Court 

Lake Forest, CA 92630 

Facsimile: (949) 639-4332 

Attention: General Counsel 

with a copy to: 

Simpson Thacher & Bartlett LLP 

425 Lexington Avenue 

New York, NY 10017 

Facsimile: (212) 455-2502 

Attention: Edward P. Tolley III, Esq. 

All such notices and communications shall be deemed to have been duly given: at the time delivered by hand, if personally delivered; five
Business Days after being deposited in the mail, postage prepaid, if mailed; when answered back, if telexed; when receipt acknowledged, if telecopied; and on the next Business Day, if timely delivered to an air courier guaranteeing overnight
delivery. 
 Copies of all such notices, demands or other communications shall be concurrently delivered by the Person giving
the same to the Trustee at the address specified in the Indenture. 
 (f) Successors and Assigns. This
Agreement shall inure to the benefit of and be binding upon the successors and assigns of each of the parties, including without limitation and without the need for an express assignment, subsequent Holders of Transfer Restricted Securities;
provided, however, that this Agreement shall not inure to the benefit of or be binding upon a successor or assign of a Holder unless and to the extent such successor or assign acquired Transfer Restricted Securities from such Holder.

 (g) Counterparts. This Agreement may be executed in any number of counterparts and by the parties
hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. 

(h) Headings. The headings in this Agreement are for convenience of reference only and shall not limit or otherwise
affect the meaning hereof. 
  

 20 

 (i) Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED
IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK. 
 (j) Severability. In the event that any one or
more of the provisions contained herein, or the application thereof in any circumstance, is held invalid, illegal or unenforceable, the validity, legality and enforceability of any such provision in every other respect and of the remaining
provisions contained herein shall not be affected or impaired thereby. 
 (k) Entire Agreement. This
Agreement together with the Purchase Agreement and the Indenture (as defined in the Purchase Agreement) is intended by the parties as a final expression of their agreement and intended to be a complete and exclusive statement of the agreement and
understanding of the parties hereto in respect of the subject matter contained herein. There are no restrictions, promises, warranties or undertakings, other than those set forth or referred to herein with respect to the registration rights granted
by the Issuer and the Guarantors with respect to the Transfer Restricted Securities. This Agreement supersedes all prior agreements and understandings between the parties with respect to such subject matter. 

[Signature Page Follows] 
  

 21 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written
above. 
  

					
	Very truly yours,
	
	 APRIA HEALTHCARE GROUP INC. 

		
	By	 	 /s/ Chris A. Karkenny

		 	Name:	 	Robert S. Holcombe
		 	Title:	 	 Executive Vice President and

Chief Financial Officer

	
	 APRIA HEALTHCARE OF NEW YORK STATE, INC.

	 APRIA HEALTHCARE, INC.

	 APRIACARE MANAGEMENT SYSTEMS, INC.

	 APRIADIRECT.COM, INC.

	 CORAM, INC.

		
	By	 	 /s/ Robert S. Holcombe

		 	Name:	 	Robert S. Holcombe
		 	Title:	 	 Executive Vice President

General Counsel and Secretary

Signature Page to the Registration Rights Agreement 

			
	 CORAM ALTERNATE SITE SERVICES, INC.

	 CORAM CLINICAL TRIALS, INC.

	 CORAM HEALTHCARE CORPORATION OF ALABAMA

	 CORAM HEALTHCARE CORPORATION OF FLORIDA

	 CORAM HEALTHCARE CORPORATION OF GREATER D.C.

	 CORAM HEALTHCARE CORPORATION OF GREATER NEW YORK

	 CORAM HEALTHCARE CORPORATION OF INDIANA

	 CORAM HEALTHCARE CORPORATION OF MASSACHUSETTS

	 CORAM HEALTHCARE CORPORATION OF MICHIGAN

	 CORAM HEALTHCARE CORPORATION OF MISSISSIPPI

	 CORAM HEALTHCARE CORPORATION OF NEVADA

	 CORAM HEALTHCARE CORPORATION OF NEW YORK

	 CORAM HEALTHCARE CORPORATION OF NORTH TEXAS

	 CORAM HEALTHCARE CORPORATION OF NORTHERN CALIFORNIA

	 CORAM HEALTHCARE CORPORATION OF SOUTH CAROLINA

	 CORAM HEALTHCARE CORPORATION OF SOUTHERN CALIFORNIA

	 CORAM HEALTHCARE CORPORATION OF SOUTHERN FLORIDA

	 CORAM HEALTHCARE CORPORATION OF UTAH

	 CORAM HEALTHCARE OF WYOMING, L.L.C.

	 CORAM HOMECARE OF MINNESOTA, INC.

	 CORAM SERVICE CORPORATION

	 CORAM SPECIALTY INFUSION SERVICES, INC.

	 CORAMRX, LLC

	 H.M.S.S., INC.

	 HEALTHINFUSION, INC.

	
T2
MEDICAL, INC.

		
	By	 	 /s/ Michael E. Dell

	 Name:
	 	Michael E. Dell
	 Title:
	 	V.P., General Counsel & Secretary

Signature Page to the Registration Rights Agreement 

 The foregoing Registration Rights Agreement is hereby confirmed and accepted as of the date first above
written: 
  

					
	 BANC OF AMERICA SECURITIES LLC

	 WACHOVIA CAPITAL MARKETS, LLC

	 BARCLAYS CAPITAL INC.

	 SCOTIA CAPITAL (USA) INC.

		
	By:	 	Banc of America Securities LLC
		
	By	 	 /s/ John McCusker

		 	Name:	 	John McCusker
		 	Title:	 	Managing Director

 Signature Page to the
Registration Rights Agreement 

 SCHEDULE A 

Guarantors 
  

			
	 Subsidiary
	  	 Jurisdiction of Organization

	Apria Healthcare of New York State, Inc.	  	New York
	Apria Healthcare, Inc.	  	Delaware
	ApriaCare Management Systems, Inc.	  	Delaware
	ApriaDirect.Com, Inc.	  	Delaware
	Coram Alternate Site Services, Inc.	  	Delaware
	Coram Clinical Trials, Inc.	  	Delaware
	Coram Healthcare Corporation of Alabama	  	Delaware
	Coram Healthcare Corporation of Florida	  	Delaware
	Coram Healthcare Corporation of Greater D.C.	  	Delaware
	Coram Healthcare Corporation of Greater New York	  	New York
	Coram Healthcare Corporation of Indiana	  	Delaware
	Coram Healthcare Corporation of Massachusetts	  	Delaware
	Coram Healthcare Corporation of Michigan	  	Delaware
	Coram Healthcare Corporation of Mississippi	  	Delaware
	Coram Healthcare Corporation of Nevada	  	Delaware
	Coram Healthcare Corporation of New York	  	New York
	Coram Healthcare Corporation of North Texas	  	Delaware
	Coram Healthcare Corporation of Northern California	  	Delaware
	Coram Healthcare Corporation of Southern California	  	Delaware
	Coram Healthcare Corporation of South Carolina	  	Delaware
	Coram Healthcare Corporation of Southern Florida	  	Delaware
	Coram Healthcare Corporation of Utah	  	Delaware
	Coram Healthcare of Wyoming, L.L.C.	  	Delaware
	Coram Homecare of Minnesota, Inc.	  	Delaware
	Coram Specialty Infusion Services, Inc.	  	Delaware
	Coram, Inc.	  	Delaware
	CoramRx, LLC	  	Delaware
	H.M.S.S., Inc.	  	Delaware
	HealthInfusion, Inc.	  	Florida
	T2
Medical, Inc.	  	Delaware

  

 A-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00176-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00176-of-00352.parquet"}]]